Denmark – Pharmaceutical products – Rammeaftale om køb af Voranigo (vorasidenib)

Amgros I/S · Denmark government procurement

Get new Denmark Pharmaceuticals tenders by email, free: Set up alerts

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$37.7M
Est. Value
Closed
Status

Opportunity Overview

Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Voranigo (vorasidenib). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.

This notice has closed, but buyers in this sector publish new ones every month. Save the search and get an alert, in your language, the day the next one opens. Free for 14 days, cancel anytime.

Start Free

Solicitation Details

Issuing agencyAmgros I/S
CountryDenmark
CategoryPharmaceuticals
Estimated value$37.7M
PublishedSeptember 11, 2026
Procurement stageSolicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Original languageDanish — members read it in their own language
Official sourceView original notice · Get alerts for tenders like this
Last verifiedNovember 22, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Denmark

Denmark – Pharmaceutical products – Amgros 2027 1,1751.b.
Denmark – Pharmaceutical products – Amgros 2027 1,1153.a.
Denmark – Pharmaceutical products – Amgros 2027 1,855.a.
Denmark – Pharmaceutical products – Amgros 2027 1.1073.a.
Denmark – Pharmaceutical products – Amgros 2027 1,159.a.

See every Denmark Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Your 14-Day Free Trial

Free 14-day trial · cancel anytime

See who is already competing here →

Get a free Denmark Pharmaceuticals intelligence report in your inbox

A personalized report on Denmark Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.